Related Experiment Video

Updated: Sep 28, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[NOS3 gene polymorphism and left ventricular hypertrophy in patients with essential hypertension]

L O Minushkina, D A Zateĭshchikov, A A Zateĭshchikova

    Kardiologiia
    |December 21, 2002
    PubMed

    Insights

    Certain genetic variations in the nitric oxide synthase 3 (NOS3) gene are linked to left ventricular hypertrophy and diastolic dysfunction in patients with essential hypertension.

    Area of Science:

    • Cardiovascular Genetics
    • Molecular Biology
    • Hypertension Research

    Context:

    • Essential hypertension is a common condition associated with significant cardiovascular risks.
    • Left ventricular hypertrophy (LVH) and diastolic dysfunction are key indicators of hypertensive heart disease.
    • The nitric oxide synthase 3 (NOS3) gene plays a crucial role in vascular function and blood pressure regulation.

    Purpose:

    • To investigate the association between specific NOS3 gene polymorphisms (Glu298Asp and ecNOS4a/4b) and the presence of left ventricular hypertrophy (LVH) and diastolic dysfunction in patients with essential hypertension.

    Summary:

    • This study analyzed 109 patients with essential hypertension, assessing for LVH via echocardiography and NOS3 polymorphisms using PCR.
    • A higher prevalence of the Glu/Glu genotype for NOS3 (Glu298Asp) was observed in patients with LVH (p=0.047).
    • Patients carrying the 4a allele of ecNOS4a/4b exhibited higher Amax values, indicating impaired diastolic function (p=0.040).

    Impact:

    • Findings suggest that the Glu allele of NOS3 (Glu298Asp) may be a genetic risk factor for developing left ventricular hypertrophy in essential hypertension.
    • The 4a allele of ecNOS4a/4b is associated with diastolic dysfunction, highlighting its potential role in hypertensive cardiovascular complications.
    • These genetic insights could inform personalized risk assessment and therapeutic strategies for essential hypertension.

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Mitral Regurgitation I: Introduction01:20

    Mitral Regurgitation I: Introduction

    Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    Single Nucleotide Polymorphisms-SNPs01:05

    Single Nucleotide Polymorphisms-SNPs

    A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...